Because LACTB was shown previously to exert tumor suppressor properties in cancers of epithelial origin, we focused our attention on analyzing the two types of ovary adenocarcinomas: mucinous and serous, which belong to type I and type II of ovarian cancers, respectively. The gene discussed is LACTB; the disease is neoplasm.